Table 3. Effects of mTOR inhibition by rapamycin on miRNA-induced senescence and DDR.
| Pre-miRNA | SA-β-gal staining upon rapamycin (% change)a | P-value | γH2AX staining upon rapamycin (% change)b | P-value |
|---|---|---|---|---|
| Pre-miR-control | −16.2 | 0.4711 | +2.56 | 0.8520 |
| Pre-miR-210 | −43 | 0.0498 | −2.34 | 0.0808 |
| Pre-miR-376a* | −37.6 | 0.0052 | −2.75 | 0.2354 |
| Pre-miR-486-5p | −15.3 | 0.2526 | +7.69 | 0.5734 |
| Pre-miR-494 | −46.2 | 0.0050 | −6.59 | >0.999 |
| Pre-miR-542-5p | −38.9 | 0.0262 | +6.38 | 0.9360 |
Starting 24 h after transfection with the indicated miRNAs, cells were treated for 3 days with 10 nM rapamycin or vehicle, and then stained for SA-β-gal. Counts of at least 300 cells were averaged and expressed as percentage of SA-β-gal-stained cells. Reduction in the percentage of positive cells upon rapamycin treatment is reported.
Starting 24 h after transfection with the indicated miRNAs, cells were treated for 3 days with 10 nM rapamycin or vehicle, and then examined by immunofluorescence for γH2AX. Counts of at least 300 cells were averaged and expressed as percent of cells with γH2AX foci. Change in the percentage of positive cells upon rapamycin treatment is reported.